PreppinPeppers › Facts › Lab article
Tesamorelin: Reference Overview and Reconstitution Notes
Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/tesamorelin.
TL;DR
Tesamorelin is a synthetic analog of growth-hormone-releasing factor (GHRH), a 44-amino-acid human protein, in the secretagogue class. Reconstitution notes.
Facts Index
| Fact ID | Category | Entity | Attribute | Value | Source |
|---|---|---|---|---|---|
| tesamorelin:title | identity | Tesamorelin: Reference Overview and Reconstitution Notes | title | Tesamorelin: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:published | identity | Tesamorelin: Reference Overview and Reconstitution Notes | published | 2026-08-15 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:author | identity | Tesamorelin: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:topics | identity | Tesamorelin: Reference Overview and Reconstitution Notes | topics | FDA-approved or specific-use, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:summary | content | Tesamorelin: Reference Overview and Reconstitution Notes | summary | Tesamorelin is a synthetic analog of growth-hormone-releasing factor (GHRH), a 44-amino-acid human protein, in the secretagogue class. Reconstitution notes. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-1 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-2 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-3 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-4 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-5 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-6 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-7 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-8 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-9 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:section-11 | content | Tesamorelin: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about Tesamorelin | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:product-gansulin-metal-peptide-pen | products | Tesamorelin: Reference Overview and Reconstitution Notes | references product | Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:product-gansulin-3ml-cartridge | products | Tesamorelin: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-pubchem-ncbi-nlm-nih-gov | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | NCBI PubChem CID 16137828: Tesamorelin (C221H366N72O67S) - pubchem.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-pubmed-ncbi-nlm-nih-gov | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | Falutz et al., N Engl J Med 2007: Metabolic effects of a growth hormone-releasing factor in patients with HIV - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-dailymed-nlm-nih-gov | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | FDA/DailyMed: EGRIFTA SV (tesamorelin) label, indication and reconstitution - dailymed.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-pubmed-ncbi-nlm-nih-gov-2 | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | Dhillon, Drugs 2011: Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-pmc-ncbi-nlm-nih-gov | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | Fourman et al., JCI Insight 2020: Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
| tesamorelin:source-www-uniprot-org | source | Tesamorelin: Reference Overview and Reconstitution Notes | cites | UniProtKB/Swiss-Prot P01286: Somatoliberin (GHRH, Homo sapiens), UniProt release 2026-03 - www.uniprot.org | Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin) (evidence) |
FAQ
- What makes Tesamorelin different from natural GHRH?
- Tesamorelin shares GHRH's 44-amino-acid sequence but adds a hexenoyl group at one terminus, increasing resistance to enzymatic degradation and improving stability compared with the unmodified natural peptide.
- What is Tesamorelin's FDA approval and WADA classification?
- It has one FDA approval: reducing excess visceral fat in HIV-associated lipodystrophy (brand: Egrifta). WADA lists it as prohibited at all times under S2—growth-hormone-releasing factors subclass.
- Why is Tesamorelin shipped as lyophilized powder?
- Freeze-drying removes water to maximize shelf stability and minimize degradation during storage and transit. The powder is reconstituted with bacteriostatic water immediately before laboratory use.